|
MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
MTEM
|
Molecular Templates, Inc.
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
ONCS
|
OncoSec Medical Incorporated
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
US
|
NASDAQ
|
|
PRTG
|
Portage Biotech Inc.
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
RAIN
|
Rain Therapeutics Inc.
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RNXT
|
RenovoRx, Inc.
|
US
|
NASDAQ
|
|
SESN
|
Sesen Bio, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
SLRX
|
Salarius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
SMFR
|
Sema4 Holdings Corp.
|
US
|
NASDAQ
|